290 related articles for article (PubMed ID: 19297612)
1. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.
Wong CS; Pierce CB; Cole SR; Warady BA; Mak RH; Benador NM; Kaskel F; Furth SL; Schwartz GJ;
Clin J Am Soc Nephrol; 2009 Apr; 4(4):812-9. PubMed ID: 19297612
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria: not a small problem in the little ones.
Schaefer F
Clin J Am Soc Nephrol; 2009 Apr; 4(4):696-7. PubMed ID: 19339420
[No Abstract] [Full Text] [Related]
3. Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease.
Hooper SR; Gerson AC; Butler RW; Gipson DS; Mendley SR; Lande MB; Shinnar S; Wentz A; Matheson M; Cox C; Furth SL; Warady BA
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1824-30. PubMed ID: 21737850
[TBL] [Abstract][Full Text] [Related]
4. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
Fathallah-Shaykh SA; Flynn JT; Pierce CB; Abraham AG; Blydt-Hansen TD; Massengill SF; Moxey-Mims MM; Warady BA; Furth SL; Wong CS
Clin J Am Soc Nephrol; 2015 Apr; 10(4):571-7. PubMed ID: 25635034
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease.
Omae K; Ogawa T; Nitta K
Heart Vessels; 2010 May; 25(3):203-8. PubMed ID: 20512447
[TBL] [Abstract][Full Text] [Related]
6. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
Ng DK; Schwartz GJ; Warady BA; Furth SL; Muñoz A
Am J Kidney Dis; 2017 Sep; 70(3):397-405. PubMed ID: 28549535
[TBL] [Abstract][Full Text] [Related]
7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
8. Hemoglobin differences by race in children with CKD.
Atkinson MA; Pierce CB; Zack RM; Barletta GM; Yadin O; Mentser M; Warady BA; Furth SL
Am J Kidney Dis; 2010 Jun; 55(6):1009-17. PubMed ID: 20418001
[TBL] [Abstract][Full Text] [Related]
9. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy.
Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C
Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229
[TBL] [Abstract][Full Text] [Related]
10. Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.
Navaneethan SD; Nigwekar SU; Sehgal AR; Strippoli GF
Clin J Am Soc Nephrol; 2009 Mar; 4(3):542-51. PubMed ID: 19261819
[TBL] [Abstract][Full Text] [Related]
11. Dyslipidemia in children with chronic kidney disease.
Saland JM; Pierce CB; Mitsnefes MM; Flynn JT; Goebel J; Kupferman JC; Warady BA; Furth SL;
Kidney Int; 2010 Dec; 78(11):1154-63. PubMed ID: 20736985
[TBL] [Abstract][Full Text] [Related]
12. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study.
Furth SL; Cole SR; Moxey-Mims M; Kaskel F; Mak R; Schwartz G; Wong C; Muñoz A; Warady BA
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1006-15. PubMed ID: 17699320
[TBL] [Abstract][Full Text] [Related]
13. Antiproteinuric therapy and fabry nephropathy: sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-beta.
Tahir H; Jackson LL; Warnock DG
J Am Soc Nephrol; 2007 Sep; 18(9):2609-17. PubMed ID: 17656478
[TBL] [Abstract][Full Text] [Related]
14. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
Ruggenenti P; Perna A; Tonelli M; Loriga G; Motterlini N; Rubis N; Ledda F; Rota S; Satta A; Granata A; Battaglia G; Cambareri F; David S; Gaspari F; Stucchi N; Carminati S; Ene-Iordache B; Cravedi P; Remuzzi G;
Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
[TBL] [Abstract][Full Text] [Related]
15. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
[TBL] [Abstract][Full Text] [Related]
16. A cluster randomized trial of an enhanced eGFR prompt in chronic kidney disease.
Manns B; Tonelli M; Culleton B; Faris P; McLaughlin K; Chin R; Gooch K; McAlister FA; Taub K; Thorlacius L; Krause R; Kearns M; Hemmelgarn B;
Clin J Am Soc Nephrol; 2012 Apr; 7(4):565-72. PubMed ID: 22344504
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 2005 Jul; 46(1):45-51. PubMed ID: 15983956
[TBL] [Abstract][Full Text] [Related]
18. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
19. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
Bianchi S; Bigazzi R; Campese VM
Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
[TBL] [Abstract][Full Text] [Related]
20. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
